Ventana's proprietary chewing gum contains an extract of
hoodia gordonii and 2-hydroxyoleic acid. Ventana Biotech Inc is developing a appetite-suppressing chewing gum. The active ingredients in the plant extracts are released into the patient's blood stream, and trigger a hormonal response in the part of the brain (the hypothalamus) that tells the body it is "full", thereby suppressing the appetite of the obese patient. Because the plant extracts activate hormones that naturally exist in the body, there are no harmful side effects.
With Ventana's proprietary Anti-Obesity Chewing Gum, users can safely control their appetites. Early indications show the Gum is able to reduce appetite by between 15 and 25 percent. Ventana continues to perfect this promising biotechnology and plans to eventually out-license it to Big Pharma companies.
Source: Medical News Today
0 comments:
Post a Comment